Aliphatic side-chain:
Chlorpromazine.
Piperidine side-chain:
Periciazine.
Piperazine side-chain:
Fluphenazine.
The Aliphatic and Piperidine compounds has a low potency, thus can little EPS effects be expected. The side effects associated with these compounds are severe sedation, strong anti-cholinergic effects, strong alphalytic effects (e.g. postural hypotension) and these medications can also cause cardiotoxicity.
The Piperazine compounds has a very high potency, thus can more EPS effects be expected with the use of these compounds. They do, however have weaker anti-chlinergic effects, weaker alphalytic effects, less sedation and also less CVS side effects.
Serotonin 2A receptors
The atypical drugs has a stronger anatgonism of Serotonin 2A receptors than for the Dopamine 2 receptors. Where the typical drugs only has an affinity for the Mesolimbic D2 receptors.
Dopamine 3 receptors
Butyrophenone derivatives (Haloperidol and Droperidol), these medications are very potent Dopamine 2 blockers.
Alpha-receptors.